Insulin is essential for managing blood sugar in type 2 diabetes, helping the body use sugar for energy. Different types of insulin, such as rapid-acting and long-acting, affect the body differently ...
Hospitalized patients with complex dietary restrictions often develop hyperglycemia, or high blood sugar. This occurs in roughly one-quarter to one-half of these patients and can lead to serious ...
Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...
It is estimated that approximately 25%–30% of hospitalized adults have diabetes. Numerous studies have demonstrated the benefits of technological advances such as continuous glucose monitoring (CGM) ...
There may be another leap toward an artificial pancreas thanks to new research released by Animas Corp. At the Advanced Technologies & Treatments for Diabetes Conference in February, the company, part ...
MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...
The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...
Control of blood glucose levels in patients with type 2 diabetes decreases the risk of complications; nevertheless, this goal can be difficult to achieve. The introduction of BASAL INSULIN ANALOGUES, ...
Looking to the European market, digital therapeutics company Amalgam Rx has scored an E.U. CE Mark for its insulin titration algorithm, called iSage Rx, and its white-label variants. This comes more ...
Sliding scale insulin therapy uses your pre-meal blood sugar level to determine insulin dosage. Research indicates sliding scale insulin therapy is ineffective at managing blood sugar levels.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results